1 research outputs found

    Epilepsia farmacorresistente. Experiencia quir煤rgica en el Instituto de Neurolog铆a y Neurocirug铆a (2012-2018)

    No full text
    Introduction: Epilepsy is the most frequent neurological alteration in the general population. The objective of epilepsy surgery is to guarantee the absence or the decrease of seizures which is achieved in 67 % and 80 % of patients.Objective: To evaluate the surgical outcome and the factors for good outcome in patients with drug-resistant epilepsy (DRE) who underwent surgical treatment at the Institute of Neurology and Neurosurgery.Material and Methods: A retrospective prospective observational study was conducted at the Institute of Neurology and Neurosurgery between January 2012 and May 2018.Results: Of all the patients studied, 44,8 % were between 21 and 30 years old, 62,1 % were male and 82,8 % were white. Also, 31 % were between 11 and 20 years of follow-up. Epilepsy was lesional in 75,9 % of patients whereas in 55,2 % of them it was located in the temporal lobe; clinical congruence was demonstrated in 86,2 % of patients. Resective techniques were used in 87,6 % of them. Besides, 82,8 % had no postoperative seizures. There were no complications in 62,1 % of patients.聽 On the other hand, 55 and 82 % of the patients studied were classified as Engel Class I and Engel Class II at 3, 6 and 12 months after surgical intervention.Conclusions: The use of resective techniques and the absence of seizures after surgery predominated in our study. No significant relationship was found between surgical outcome, etiology of epilepsy and clinical congruence. The presence of a focal lesion of the temporal lobe was a factor for good outcome.聽Introducci贸n: La epilepsia es la alteraci贸n neurol贸gica m谩s frecuente en la poblaci贸n general. El objetivo de la cirug铆a de epilepsia es garantizar la ausencia o disminuci贸n de crisis, lo que se logra en el 80 % de los pacientes.Objetivo: Evaluar la evoluci贸n posquir煤rgica y factores de buen pron贸stico de los pacientes intervenidos de epilepsia farmacorresistente (EFR) en el Instituto de Neurolog铆a y Neurocirug铆a.Material y M茅todos: Se realiz贸 un estudio observacional descriptivo retro y prospectivo en el Instituto de Neurolog铆a y Neurocirug铆a entre enero de 2012 a mayo de 2018.Resultados: La edad del 44,8 % de los pacientes estuvo entre 21 y 30 a帽os, el 62,1 % era del sexo masculino y el 82,8 % ten铆a color de piel blanca, el 31 % present贸 entre 11 y 20 a帽os de evoluci贸n. En el 75,9 % la epilepsia era lesional, el 55,2 % con localizaci贸n temporal y en el 86,2 % se demostr贸 congruencia cl铆nica. Se utilizaron t茅cnicas resectivas en 87,6 %. El 82,8 % no present贸 crisis postoperatorias. En 62,1 % no se presentaron complicaciones. A los 3, 6 y 12 meses despu茅s de la intervenci贸n entre el 55 al 82 % de los pacientes estudiados se clasificaron como Engel clase I y clase II.Conclusiones: En nuestro estudio predomin贸 la utilizaci贸n de t茅cnicas resectivas y la ausencia de crisis posterior a la cirug铆a. No se registr贸 relaci贸n significativa entre la evoluci贸n posquir煤rgica, la etiolog铆a de la epilepsia y la congruencia cl铆nica. La presencia de lesi贸n focal en el l贸bulo temporal constituy贸 un factor de buen pron贸stico
    corecore